Order Article Reprints

Ziebarth J, da Silva LM, Lorenzett AKP, Figueiredo ID, Carlstrom PF, Cardoso FN, de Freitas ALF, Baviera AM, Mainardes RM. Oral Delivery of Liraglutide-Loaded Zein/Eudragit-Chitosan Nanoparticles Provides Pharmacokinetic and Glycemic Outcomes Comparable to Its Subcutaneous Injection in Rats. Pharmaceutics. 2024; 16(5):634. https://doi.org/10.3390/pharmaceutics16050634

Ziebarth, Jeferson, Letícia Marina da Silva, Ariane Krause Padilha Lorenzett, Ingrid Delbone Figueiredo, Paulo Fernando Carlstrom, Felipe Nunes Cardoso, André Luiz Ferreira de Freitas, Amanda Martins Baviera, and Rubiana Mara Mainardes. 2024. "Oral Delivery of Liraglutide-Loaded Zein/Eudragit-Chitosan Nanoparticles Provides Pharmacokinetic and Glycemic Outcomes Comparable to Its Subcutaneous Injection in Rats" Pharmaceutics 16, no. 5: 634. https://doi.org/10.3390/pharmaceutics16050634

Ziebarth, J., da Silva, L. M., Lorenzett, A. K. P., Figueiredo, I. D., Carlstrom, P. F., Cardoso, F. N., de Freitas, A. L. F., Baviera, A. M., & Mainardes, R. M. (2024). Oral Delivery of Liraglutide-Loaded Zein/Eudragit-Chitosan Nanoparticles Provides Pharmacokinetic and Glycemic Outcomes Comparable to Its Subcutaneous Injection in Rats. Pharmaceutics, 16(5), 634. https://doi.org/10.3390/pharmaceutics16050634